Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 301Other hematologic neoplasm 104Dermatologic 9Plasma cell 7Sarcoma 5Myeloid 5Thoracic 2Head & Neck 2Gynecologic 2Genitourinary 2CNS 2Breast 2Gastrointestinal 1Classical hematology 1

Conditions

Pancreatic Neoplasms 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lung Neoplasms 1Head and Neck Neoplasms 1Colonic Neoplasms 1

Interventions

aflibercept 2Radiotherapy 2Gemcitabine 2Capecitabine 2pembrolizumab 1pasireotide 1motexafin gadolinium 1fludarabine 1entinostat 1Watchful Waiting 1Topotecan 1Thalidomide 1Rituximab 1Ritonavir 1Radiation 1Polymerase Chain Reaction 1Nicotine 1Microarray Analysis 1Leucovorin 1Ipilimumab 1Interleukin-2 1Indinavir 1Immunoenzyme Techniques 1Imatinib Mesylate 1HMPL-013 1Gene Expression Profiling 1Fluorouracil 1Flow Cytometry 1Fentanyl 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × Rituximab × Gastrointestinal × Clear all
NCT03997968 2024-12-24

A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

Cyteir Therapeutics, Inc.

Phase 1/2 Completed
169 enrolled
BreastGastrointestinalGynecologicHead & NeckLymphoidPlasma cellSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Head and Neck Neoplasms, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Lymphoma, Mantle-Cell, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡